Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathwayV. Wong(University of Toronto), Gary F. Lewis(University of Toronto)Journal of EndocrinologyAugust 1, 200610.1677/joe.1.06396Cited by 10SaveCiteExport RISWatch citationsRelated PapersAcute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice|Diabetologia|2011|30α-Tubulin Acetyltransferase Is a Novel Target Mediating Neurite Growth Inhibitory Effects of Chondroitin Sulfate Proteoglycans and Myelin-Associated Glycoprotein|eNeuro|2018|18